Artificial Intelligence in Autoimmune Disease Genomics: A review of Advances in Biomarker Discovery and Pathway Analysis in Multiple Sclerosis
سال انتشار: 1405
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 30
فایل این مقاله در 27 صفحه با فرمت PDF قابل دریافت می باشد
- صدور گواهی نمایه سازی
- من نویسنده این مقاله هستم
استخراج به نرم افزارهای پژوهشی:
شناسه ملی سند علمی:
JR_IJABBR-14-4_004
تاریخ نمایه سازی: 21 آبان 1405
چکیده مقاله:
Multiple sclerosis (MS) is a chronic autoimmune disease of the central nervous system characterized by immune-mediated neuroinflammation, demyelination, and progressive disability. Despite the identification of over ۲۳۰ susceptibility loci, the complexity of multi-omics data hinders the translation of genomic findings into actionable biomarkers and mechanistic insights. This narrative review synthesizes the current evidence on artificial intelligence (AI) applications in MS genomics, with a focus on biomarker discovery, pathway analysis, and translational opportunities. A comprehensive literature search was conducted across biomedical and engineering databases. Studies applying AI techniques, including machine learning, deep learning, and reinforcement learning, to MS genomic, transcriptomic, proteomic, metabolomic, or imaging data were thematically synthesized. AI approaches indicate strong potential in MS research. Machine learning has identified diagnostic and prognostic biomarkers with higher accuracy than traditional methods. Deep learning has improved lesion detection and enabled multimodal integration of MRI and omics data. Emerging reinforcement learning frameworks are being explored for treatment optimization. AI-driven pathway analysis has revealed immune signaling networks that may inform therapeutic targeting. However, challenges such as data heterogeneity, limited cohort diversity, and regulatory considerations remain. AI is advancing MS genomics by facilitating biomarker discovery and understanding disease mechanisms. While most applications are still in the proof-of-concept stage, continued validation, transparency, and responsible data governance are essential for clinical translation toward precision medicine in MS and autoimmune diseases.
کلیدواژه ها:
نویسندگان
- -
Department of Bioinformatics, School of Health and Life Sciences, Teesside University, United Kingdom
- -
Department of Microbiology, Faculty of Life Sciences, University of Benin, Benin City, Edo State, Nigeria
- -
Department of Computing, East Tennessee State University, Tennessee, USA
- -
Department of Biology, Faculty of Natural and Applied Sciences, Gregory University Uturu, Abia State, Nigeria
- -
Department of Biochemistry, Ladoke Akintola University of Technology, Ogbomosho, Nigeria
مراجع و منابع این مقاله:
لیست زیر مراجع و منابع استفاده شده در این مقاله را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود مقاله لینک شده اند :